| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.28 | 9e-16 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-15 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.34 | 4e-13 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-13 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-13 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.26 | 9e-12 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |